David Joseph Rosa - 24 Oct 2025 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Reporting relationship: Chief Executive Officer (CEO), Director
Issuer ticker: ISRG
Reported as of: 24 Oct 2025
Net transaction value: -$11,264,759
SEC form: 4
Accepted by SEC: 27 Oct 2025, 15:36:53 UTC
Prior SEC filing: 11 Jul 2025
Next SEC filing: 03 Nov 2025
Source filing: View source filing
Reporting owner signature: By: Stephanie Lim-Ignacio For: Rosa, David J

Key filing fact

David Joseph Rosa filed Form 4 for INTUITIVE SURGICAL INC (ISRG) on 27 Oct 2025.

Key facts

This page summarizes David Joseph Rosa's Form 4 filing for INTUITIVE SURGICAL INC (ISRG).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 27 Oct 2025, 15:36.

Change

Previous filing in this sequence was filed on 11 Jul 2025.
Current net transaction value: -$11,264,759.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001519593 Primary reporting owner

Rosa David J.

Relationship: Chief Executive Officer (CEO), Director
Address: 1020 KIFER ROAD, SUNNYVALE
Signature: By: Stephanie Lim-Ignacio For: Rosa, David J
Signature date: 27 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ISRG transaction

Common Stock

Options Exercise

Transaction value: $2,150,221
Shares: +27,000
Change %: +12%
Price: $79.64
Shares after: 258,756
Date: 24 Oct 2025
Ownership: Direct
Footnotes: F1

ISRG transaction

Common Stock

Sale

Transaction value: $13,414,980
Shares: -24,500
Change %: -9.5%
Price: $547.55
Shares after: 234,256
Date: 24 Oct 2025
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ISRG transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -27,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 24 Oct 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 27,000
Exercise price: $79.64
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 11, 2026.

Footnote F2

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $542.16 to $550.21 as follows: 1,075 shares sold at $542.16 to $543.10; 1,000 shares sold at $543.23 to $544.22; 1,830 shares sold at $544.30 to $545.06; 1,300 shares sold at $545.33 to $546.15; 2,346 shares sold at $546.34 to $547.30; 6,919 shares sold at $547.37 to $548.37; 7,257 shares sold at $548.40 to $549.40; and 2,773 shares sold at $549.42 to $550.21. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F3

Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.